课题基金 / 基金详情

Development of a novel technology for in-vitro assessment of exposure to fine and ultrafine particulate matter

Development of a novel technology for in-vitro assessment of exposure to fine and ultrafine particulate matter
开发体外评估细颗粒物和超细颗粒物暴露的新技术
批准号:
350831-2008
负责人:
Evans, Greg
金额:
$5.17万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Health Research Projects
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-01-01 至 2010-12-31

项目摘要

项目成果

Evans, Greg的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Air pollution has a major impact on the health of Canadians that, in Ontario alone, costs an estimated at $8 billion dollars annually. Particulate matter has been implicated as one of the major air pollutants causing this illness. However, very little is actually known about which chemical or physical characteristics of the particulate matter are causing these adverse health impacts. It is believed that following inhalation of particulate matter, our body responds at a cellular level triggering a cascade of biological processes that lead to the impact that we experience, impacts that range from discomfort in breathing to fatal heart attacks. In addition, particulate matter from some sources is likely much more toxic than that from others. Hence studying the relationship between particulate matter composition and cellular response, at locations where the particulate matter is expected to be more toxic or concentrated, will provide a key link between our health and our environment. The overall goal of this collaborative health research project is to develop a transportable system for exposing lung cells to particulate matter at different locations of interest. The system will separate the particulate matter by size into two fractions prior to contact with the cells. The first fraction, called the "fine" fraction, will contain the particles smaller than 2.5 mm in diameter (PM2.5) whereas the second fraction, called the ultrafine fraction, will contain particles that are over 100 times smaller. This sized based distinction is very important, as these fractions are quite different both in the environment and in our bodies. We will use it this system to explore the biological response of cells when exposed to different concentrations of particulate matter and to assess different locations in which the particulate matter is believed to be more hazardous. The project will bring together a multidisciplinary team from medicine, engineering and science, along with collaborators from different levels of government. The understanding arising from this project will support the development of more effective air quality and emission regulations so as to protect the public without unnecessarily constraining economic growth.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clean Air for All: Assessment and Mitigation of Urban Air Pollution
  • 批准号:
    RGPIN-2021-02707
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.66万
  • 财政年份:
    2022
  • 负责人:
    Evans, Greg
  • 依托单位:
Nominated for the NSERC Brockhouse Canada Prize
  • 批准号:
    549306-2021
  • 项目类别:
    Brockhouse Canada Prize for Interdisciplinary Research in Science and Engineering
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Evans, Greg
  • 依托单位:
Measuring Air Quality To Manage Canada's Investment In Sustainability
  • 批准号:
    570774-2021
  • 项目类别:
    Alliance Grants
  • 资助金额:
    $20.83万
  • 财政年份:
    2021
  • 负责人:
    Evans, Greg
  • 依托单位:
Clean Air for All: Assessment and Mitigation of Urban Air Pollution
  • 批准号:
    RGPIN-2021-02707
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.66万
  • 财政年份:
    2021
  • 负责人:
    Evans, Greg
  • 依托单位:
国内基金
海外基金
Novel-miR-1134调控LHCGR的表达介导拟 穴青蟹卵巢发育的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    崔文晓
  • 依托单位:
novel-miR75靶向OPR2,CA2和STK基因调控人参真菌胁迫响应的分子机制研究
  • 批准号:
    82304677
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    边兴博
  • 依托单位:
海南广藿香Novel17-GSO1响应p-HBA调控连作障碍的分子机制
  • 批准号:
    82304658
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    刘亚
  • 依托单位:
白术多糖通过novel-mir2双靶向TRADD/MLKL缓解免疫抑制雏鹅的胸腺程序性坏死
  • 批准号:
    32102747
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李婉雁
  • 依托单位: